8 European Projects Found
Searched on 125080 European Projects
FINISHED
Ex vivo Re-vascularization in Porcine Liver Bioengineering - A Critical First Step Towards Effective Transplantation of Bioengineered Livers (Liver Bioengineering)
Start date: Aug 1, 2015, End date: Jul 31, 2017,
Liver transplantation is currently the only proven therapy to extend life of patients with terminal liver disease. Organ bioengineering and regenerative medicine are promising new technologies that can help reduce the burden of liver shortage by increasing the number of organs available for transplantation. However, current bioengineered livers lack a functional vascular network that can readily a ...
Read Project
1
Partner Participant
FINISHED
Identification and validation of cerebral KCa3.1/KCa2.3 potassium channels a drug tragets for the prevention and treatment of cerebral ischemia associated with diabetes and Alzheimers disease (BrainIK)
Start date: Oct 1, 2012, End date: Sep 30, 2016,
The objectives of the project are to identify and evaluate potassium channels of the KCa3.1/KCa2.X type as novel drug targets for the prevention and treatment of cerebrovascular ischemia and neuroprotection in metabolic disease and neurodegenerative disorders associated with vascular pathologies, as a new pathophysiological concept and treatment strategy.To reach these aims, the proponent employs ...
Read Project
1
Partner Participant
FINISHED
Apolipoprotein E gene in the Metabolic Syndrome (APOMET)
Start date: May 1, 2012, End date: Apr 30, 2016,
"Metabolic Syndrome (MetS) is closely linked to disturbances in lipid and glucose metabolism and increases the risk of developing cardiovascular disease and diabetes. One-fourth of the adult European population has the MetS and a further increase is anticipated because a greater prevalence of obesity in the future. Apolipoprotein E (APOE) associates with lipoproteins and mediates theirmetabolism. ...
Read Project
1
Partner Participant
FINISHED
Red Transfronteriza de Investigación Biomédica de los Pirineos- Establecimiento de una Red de colaboración estable entre Centros de Investigación Biomédica en el espacio Pirineos (BIOMED-PIRINEOS)
Start date: May 31, 2012, End date: Nov 29, 2014,
...Servet (líder) ,Institute National de la Santé et de la Recherche Médicale (INSERM) de Midi Pyrénées Limousin,Instituto Aragonés de Ciencias de la Salud (IACS), Université Paul Sabatier de Toulouse, Centre Hospitalier Universitaire de Toulouse (CHU), Fundación Vasca de Innovación e Investigación Sanitarias (BIOEF), Centro de Investigación Biomédica de La Rioja (CIBIR) e Instituto de Investigación ...
Read Project
8
Partners Participants
FINISHED
MITOCHONDRIAL RESPIRATORY CHAIN ASSEMBLY (MRCA)
Start date: Apr 10, 2009, End date: Jun 8, 2014,
"Oxidative phosphorylation (OXPHOS) is the metabolic process that provides most of the energy usable by the cells. OXPHOS couples two sets of reactions, respiration and ATP synthesis. Respiration consists in the sequential transfer of electrons carried out by the mitochondrial respiratory chain (MRC) complexes I (CI), II (CII), III (CIII), and IV (CIV). The proton gradient generated during respira ...
Read Project
2
Partners Participants
FINISHED
European Collaboration for Healthcare Optimization (ECHO)
Start date: Mar 1, 2010, End date: Feb 28, 2014,
"ECHO, European Collaboration for Healthcare Optimization, gathers the interests for Healthcare Performance Measurement of different Academic and Research Institutions from six European countries and an International Body for Healthcare Policy Analysis. Designed as a 48 months project, it has been conceived as a “pilot study” based on available administrative databases. It aims at describing the a ...
Read Project
8
Partners Participants
FINISHED
Building a cooperative strategy between Europe and Mediterranean Countries for upgrading tuberculosis research and control (EUMEDNETvsTB)
Start date: Mar 1, 2010, End date: Feb 28, 2013,
Tuberculosis (TB) accounts amongst the most deadly infectious diseases worldwide. Despite the availability of a vaccine and effective drugs, Mycobacterium tuberculosis, the etiologic agent of TB, still defies the humanity. An alarming increase in drug resistance and emergence of outbreaks has made it urgent the need for increased surveillance and control. With its structured global geographical di ...
Read Project
7
Partners Participants
FINISHED
Chip Architectures by Joint Associated Labs for European Diagnostics (CAJAL4EU)
Start date: Mar 1, 2010, End date: Feb 1, 2013,
The main objective of the ENIAC JU project CAJAL4EU is to develop miniaturised biosensor technology platforms enabling diagnostic test manufacturers to build multi-parameter in-vitro test applications rapidly in a robust, user-friendly and cost-effective way. They will involve nanoelectronic-based transducers with chemical sensing capabilities providing the interface with the clinical samples. In ...
Read Project
